APO Research
Talk to an analyst

APO RESEARCH · REPORT

Assisted Reproductive Technologies Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Assisted Reproductive Technologies Medications Industry Growth and Trends Forecast to 2032

20 December 2025104 pages

Choose your research edition.

Industry ResearchAssisted Reproductive Technologies Medications Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Assisted Reproductive Technologies Medications Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Assisted Reproductive Technologies Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Assisted Reproductive Technologies Medications Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Assisted Reproductive Technologies Medications Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Assisted Reproductive Technologies Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Assisted Reproductive Technologies Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Assisted Reproductive Technologies Medications market include Zhejiang Xianju, Merck Serono, Livzon Pharmaceutical, Changchun GeneScience, Hybio Pharmaceutical, Solvay, Organon, Ipsen and Ferring, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Assisted Reproductive Technologies Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Assisted Reproductive Technologies Medications market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Assisted Reproductive Technologies Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Assisted Reproductive Technologies Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Assisted Reproductive Technologies Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Assisted Reproductive Technologies Medications Market by Company

Zhejiang Xianju

Merck Serono

Livzon Pharmaceutical

Changchun GeneScience

Hybio Pharmaceutical

Solvay

Organon

Ipsen

Ferring

Besins

Assisted Reproductive Technologies Medications Segment by Type

Ovulation Stimulation Drugs

Luteal Support Medications

Down-Regulation Drugs

Ovulation Inducing Drugs

Assisted Reproductive Technologies Medications Segment by Application

Specialty & Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Assisted Reproductive Technologies Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Assisted Reproductive Technologies Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Assisted Reproductive Technologies Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Assisted Reproductive Technologies Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Assisted Reproductive Technologies Medications companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Assisted Reproductive Technologies Medications Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Assisted Reproductive Technologies Medications Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Assisted Reproductive Technologies Medications Market Share by Region (2021-2026) Table 4. Global Assisted Reproductive Technologies Medications Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Assisted Reproductive Technologies Medications Market Share by Region (2027-2032) Table 6. Global Assisted Reproductive Technologies Medications Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Assisted Reproductive Technologies Medications Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2026) Table 9. Global Assisted Reproductive Technologies Medications Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Assisted Reproductive Technologies Medications Market Size Share Forecasted by Type (2027-2032) Table 11. North America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Assisted Reproductive Technologies Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Assisted Reproductive Technologies Medications Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2026) Table 24. Global Assisted Reproductive Technologies Medications Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Assisted Reproductive Technologies Medications Market Size Share Forecasted by Application (2027-2032) Table 26. North America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Assisted Reproductive Technologies Medications Industry Trends Table 37. Assisted Reproductive Technologies Medications Industry Drivers Table 38. Assisted Reproductive Technologies Medications Industry Opportunities and Challenges Table 39. Assisted Reproductive Technologies Medications Industry Restraints Table 40. Global Assisted Reproductive Technologies Medications Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Assisted Reproductive Technologies Medications Revenue Market Share by Company (2021-2026) Table 42. Global Assisted Reproductive Technologies Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Assisted Reproductive Technologies Medications Key Company Headquarters & Area Served Table 44. Global Assisted Reproductive Technologies Medications Company, Product Type & Application Table 45. Global Assisted Reproductive Technologies Medications Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Assisted Reproductive Technologies Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Zhejiang Xianju Company Information Table 49. Zhejiang Xianju Business Overview Table 50. Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio Table 52. Zhejiang Xianju Recent Development Table 53. Merck Serono Company Information Table 54. Merck Serono Business Overview Table 55. Merck Serono Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Merck Serono Assisted Reproductive Technologies Medications Product Portfolio Table 57. Merck Serono Recent Development Table 58. Livzon Pharmaceutical Company Information Table 59. Livzon Pharmaceutical Business Overview Table 60. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 62. Livzon Pharmaceutical Recent Development Table 63. Changchun GeneScience Company Information Table 64. Changchun GeneScience Business Overview Table 65. Changchun GeneScience Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio Table 67. Changchun GeneScience Recent Development Table 68. Hybio Pharmaceutical Company Information Table 69. Hybio Pharmaceutical Business Overview Table 70. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio Table 72. Hybio Pharmaceutical Recent Development Table 73. Solvay Company Information Table 74. Solvay Business Overview Table 75. Solvay Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Solvay Assisted Reproductive Technologies Medications Product Portfolio Table 77. Solvay Recent Development Table 78. Organon Company Information Table 79. Organon Business Overview Table 80. Organon Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Organon Assisted Reproductive Technologies Medications Product Portfolio Table 82. Organon Recent Development Table 83. Ipsen Company Information Table 84. Ipsen Business Overview Table 85. Ipsen Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Ipsen Assisted Reproductive Technologies Medications Product Portfolio Table 87. Ipsen Recent Development Table 88. Ferring Company Information Table 89. Ferring Business Overview Table 90. Ferring Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Ferring Assisted Reproductive Technologies Medications Product Portfolio Table 92. Ferring Recent Development Table 93. Besins Company Information Table 94. Besins Business Overview Table 95. Besins Assisted Reproductive Technologies Medications Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Besins Assisted Reproductive Technologies Medications Product Portfolio Table 97. Besins Recent Development Table 98. North America Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Assisted Reproductive Technologies Medications Market Share by Country (2021-2026) Table 101. North America Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Assisted Reproductive Technologies Medications Market Share Forecast by Country (2027-2032) Table 103. Europe Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Assisted Reproductive Technologies Medications Market Share by Country (2021-2026) Table 106. Europe Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Assisted Reproductive Technologies Medications Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Assisted Reproductive Technologies Medications Market Share by Country (2021-2026) Table 111. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Assisted Reproductive Technologies Medications Market Share Forecast by Country (2027-2032) Table 113. Latin America Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Assisted Reproductive Technologies Medications Market Share by Country (2021-2026) Table 116. Latin America Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Assisted Reproductive Technologies Medications Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2021-2026) Table 121. Middle East & Africa Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Assisted Reproductive Technologies Medications Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Assisted Reproductive Technologies Medications Product Image Figure 3. Global Assisted Reproductive Technologies Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Assisted Reproductive Technologies Medications Market Size (2021-2032) & (US$ Million) Figure 5. Global Assisted Reproductive Technologies Medications Market Share by Region: 2025 VS 2032 Figure 6. Global Assisted Reproductive Technologies Medications Market Share by Region (2021-2032) Figure 7. North America Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ovulation Stimulation Drugs Image Figure 13. Global Ovulation Stimulation Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Luteal Support Medications Image Figure 15. Global Luteal Support Medications Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Down-Regulation Drugs Image Figure 17. Global Down-Regulation Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Ovulation Inducing Drugs Image Figure 19. Global Ovulation Inducing Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Assisted Reproductive Technologies Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Assisted Reproductive Technologies Medications Market Share by Type 2025 VS 2032 Figure 22. North America Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032) Figure 23. Europe Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032) Figure 25. Latin America Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Share by Type (2021-2032) Figure 27. Specialty & Retail Pharmacy Image Figure 28. Global Specialty & Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Hospital Pharmacy Image Figure 30. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Online Pharmacy Image Figure 32. Global Online Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Assisted Reproductive Technologies Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Assisted Reproductive Technologies Medications Market Share by Application 2025 VS 2032 Figure 35. North America Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032) Figure 36. Europe Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032) Figure 38. Latin America Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Assisted Reproductive Technologies Medications Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Assisted Reproductive Technologies Medications Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Assisted Reproductive Technologies Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Assisted Reproductive Technologies Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 45. Europe Assisted Reproductive Technologies Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Assisted Reproductive Technologies Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 48. Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Assisted Reproductive Technologies Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 51. Latin America Assisted Reproductive Technologies Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Assisted Reproductive Technologies Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 54. Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Assisted Reproductive Technologies Medications Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Ovulation Stimulation Drugs
  • Luteal Support Medications
  • Down-Regulation Drugs
  • Ovulation Inducing Drugs
Applications
  • Specialty & Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zhejiang Xianju
  • Merck Serono
  • Livzon Pharmaceutical
  • Changchun GeneScience
  • Hybio Pharmaceutical
  • Solvay
  • Organon
  • Ipsen
  • Ferring
  • Besins

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Assisted Reproductive Technologies Medications Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Assisted Reproductive Technologies Medications Market Size by Region (2021-2032)
  5. 1.4.1 Global Assisted Reproductive Technologies Medications Market Size by Region (2021-2026)
  6. 1.4.2 Global Assisted Reproductive Technologies Medications Market Size by Region (2027-2032)
  7. 1.5 Key Regions Assisted Reproductive Technologies Medications Market Size (2021-2032)
  8. 1.5.1 North America Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate (2021-2032)
2 Assisted Reproductive Technologies Medications Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ovulation Stimulation Drugs
  3. 2.1.2 Luteal Support Medications
  4. 2.1.3 Down-Regulation Drugs
  5. 2.1.4 Ovulation Inducing Drugs
  6. 2.2 Global Assisted Reproductive Technologies Medications Market Size by Type
  7. 2.2.1 Global Assisted Reproductive Technologies Medications Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Assisted Reproductive Technologies Medications Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Assisted Reproductive Technologies Medications Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Assisted Reproductive Technologies Medications Market Size by Regions
  11. 2.3.1 North America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Type (2021-2026)
3 Assisted Reproductive Technologies Medications Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Specialty & Retail Pharmacy
  3. 3.1.2 Hospital Pharmacy
  4. 3.1.3 Online Pharmacy
  5. 3.2 Global Assisted Reproductive Technologies Medications Market Size by Application
  6. 3.2.1 Global Assisted Reproductive Technologies Medications Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Assisted Reproductive Technologies Medications Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Assisted Reproductive Technologies Medications Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Assisted Reproductive Technologies Medications Market Size by Regions
  10. 3.3.1 North America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Assisted Reproductive Technologies Medications Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Assisted Reproductive Technologies Medications Industry Trends
  2. 4.2 Assisted Reproductive Technologies Medications Industry Drivers
  3. 4.3 Assisted Reproductive Technologies Medications Industry Opportunities and Challenges
  4. 4.4 Assisted Reproductive Technologies Medications Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Assisted Reproductive Technologies Medications Revenue (2021-2026)
  2. 5.2 Global Assisted Reproductive Technologies Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Assisted Reproductive Technologies Medications Key Company Headquarters & Area Served
  4. 5.4 Global Assisted Reproductive Technologies Medications Company, Product Type & Application
  5. 5.5 Global Assisted Reproductive Technologies Medications Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Assisted Reproductive Technologies Medications Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Assisted Reproductive Technologies Medications Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Assisted Reproductive Technologies Medications Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Zhejiang Xianju
  2. 6.1.1 Zhejiang Xianju Company Information
  3. 6.1.2 Zhejiang Xianju Business Overview
  4. 6.1.3 Zhejiang Xianju Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Xianju Assisted Reproductive Technologies Medications Product Portfolio
  6. 6.1.5 Zhejiang Xianju Recent Developments
  7. 6.2 Merck Serono
  8. 6.2.1 Merck Serono Company Information
  9. 6.2.2 Merck Serono Business Overview
  10. 6.2.3 Merck Serono Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Merck Serono Assisted Reproductive Technologies Medications Product Portfolio
  12. 6.2.5 Merck Serono Recent Developments
  13. 6.3 Livzon Pharmaceutical
  14. 6.3.1 Livzon Pharmaceutical Company Information
  15. 6.3.2 Livzon Pharmaceutical Business Overview
  16. 6.3.3 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Livzon Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  18. 6.3.5 Livzon Pharmaceutical Recent Developments
  19. 6.4 Changchun GeneScience
  20. 6.4.1 Changchun GeneScience Company Information
  21. 6.4.2 Changchun GeneScience Business Overview
  22. 6.4.3 Changchun GeneScience Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Changchun GeneScience Assisted Reproductive Technologies Medications Product Portfolio
  24. 6.4.5 Changchun GeneScience Recent Developments
  25. 6.5 Hybio Pharmaceutical
  26. 6.5.1 Hybio Pharmaceutical Company Information
  27. 6.5.2 Hybio Pharmaceutical Business Overview
  28. 6.5.3 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Hybio Pharmaceutical Assisted Reproductive Technologies Medications Product Portfolio
  30. 6.5.5 Hybio Pharmaceutical Recent Developments
  31. 6.6 Solvay
  32. 6.6.1 Solvay Company Information
  33. 6.6.2 Solvay Business Overview
  34. 6.6.3 Solvay Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Solvay Assisted Reproductive Technologies Medications Product Portfolio
  36. 6.6.5 Solvay Recent Developments
  37. 6.7 Organon
  38. 6.7.1 Organon Company Information
  39. 6.7.2 Organon Business Overview
  40. 6.7.3 Organon Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Organon Assisted Reproductive Technologies Medications Product Portfolio
  42. 6.7.5 Organon Recent Developments
  43. 6.8 Ipsen
  44. 6.8.1 Ipsen Company Information
  45. 6.8.2 Ipsen Business Overview
  46. 6.8.3 Ipsen Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Ipsen Assisted Reproductive Technologies Medications Product Portfolio
  48. 6.8.5 Ipsen Recent Developments
  49. 6.9 Ferring
  50. 6.9.1 Ferring Company Information
  51. 6.9.2 Ferring Business Overview
  52. 6.9.3 Ferring Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Ferring Assisted Reproductive Technologies Medications Product Portfolio
  54. 6.9.5 Ferring Recent Developments
  55. 6.10 Besins
  56. 6.10.1 Besins Company Information
  57. 6.10.2 Besins Business Overview
  58. 6.10.3 Besins Assisted Reproductive Technologies Medications Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Besins Assisted Reproductive Technologies Medications Product Portfolio
  60. 6.10.5 Besins Recent Developments
7 North America
  1. 7.1 North America Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  3. 7.3 North America Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  3. 8.3 Europe Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  3. 10.3 South America Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Assisted Reproductive Technologies Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Assisted Reproductive Technologies Medications Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Assisted Reproductive Technologies Medications Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst